VKTX Operating Income - Viking Therapeutics, Inc.

Complete source-backed operating income history.

Available history: 2014-03-31 to 2026-06-30
Data captured: 2026-09-04

Historical Operating Income

Date	Operating Income
2026-06-30	-$132.6M
2026-03-31	-$164.13M
2025-12-31	-$164.74M
2025-09-30	-$98.56M
2025-06-30	-$74.57M
2025-03-31	-$55.47M
2024-12-31	-$46.24M
2024-09-30	-$36.56M
2024-06-30	-$34.05M
2024-03-31	-$34.07M
2023-12-31	-$29.29M
2023-09-30	-$27.27M
2023-06-30	-$23.74M
2023-03-31	-$20.54M
2022-12-31	-$20.28M
2022-09-30	-$16.2M
2022-06-30	-$17.63M
2022-03-31	-$16.25M
2021-12-31	-$12.51M
2021-09-30	-$13.4M
2021-06-30	-$15.54M
2021-03-31	-$14.23M
2020-12-31	-$11.27M
2020-09-30	-$9.84M
2020-06-30	-$10.61M
2020-03-31	-$10.95M
2019-12-31	-$8.87M
2019-09-30	-$7.44M
2019-06-30	-$9.57M
2019-03-31	-$6.81M
2018-12-31	-$7.04M
2018-09-30	-$7.39M
2018-06-30	-$6.93M
2018-03-31	-$4.81M
2017-12-31	-$4.43M
2017-09-30	-$4.69M
2017-06-30	-$4.98M
2017-03-31	-$4.97M
2016-12-31	-$3.74M
2016-09-30	-$3.26M
2016-06-30	-$3.58M
2016-03-31	-$3.27M
2015-12-31	-$4.62M
2015-09-30	-$4.29M
2015-06-30	-$2.63M
2015-03-31	-$461,040.00
2014-12-31	-$353,565.00
2014-09-30	-$1.15M
2014-06-30	-$21.76M
2014-03-31	-$209,737.00

Annual Operating Income

Date	Operating Income
2025-12-31	-$393.34M
2024-12-31	-$150.92M
2023-12-31	-$100.83M
2022-12-31	-$70.36M
2021-12-31	-$55.68M
2020-12-31	-$42.66M
2019-12-31	-$32.69M
2018-12-31	-$26.16M
2017-12-31	-$19.07M
2016-12-31	-$13.85M
2015-12-31	-$12M
2014-12-31	-$23.47M